Biotech / Medical
Sorrento Therapeutics Inc
An SI Board Since January 2010
Posts SubjectMarks Bans Symbol
81 9 0 SRNE
Emcee:  alenor Type:  Unmoderated
Remember QBSW? Quikbyte did a reverse merger and is now:
"Sorrento Therapeutics, Inc. is a development-stage biopharmaceutical company focused on applying its proprietary technology platform for the discovery and development of human therapeutic antibodies for the treatment of a variety of disease conditions, including cancer, inflammation, metabolic disease and infectious disease."
Recent news starts like this:
"SAN DIEGO, Jan 11, 2010 /PRNewswire via COMTEX News Network/ --
Sorrento Therapeutics, Inc. (OTC Bulletin Board: SRNE) today announced an antibody discovery and development collaboration with The Scripps Research Institute, La Jolla, CA. Under the terms of the agreement, Sorrento Therapeutics obtains an exclusive, worldwide license to the Institute's novel technology, based on quorum sensing, for the prevention and treatment of Staphylococcus aureus ('Staph') infections, including Methicillin-resistant Staph. aureus (MRSA). ..."
***** MOST RECENT *****
SAN DIEGO, Aug. 1, 2013 /PRNewswire via COMTEX/ -- Sorrento Therapeutics, Inc. (OTCQB: SRNE; Sorrento) announced today that it has filed a Certificate of Amendment to its Restated Certificate of Incorporation to effect a 1-for-25 reverse stock split of its common stock, effective on July 30, 2013. The proposal to effect a reverse stock split was approved by the Company`s stockholders at its Special Meeting of Stockholders held on April 26, 2013, and the specific 1-for-25 ratio was subsequently approved by the Company`s Board of Directors. At the effective time of the reverse stock split, every twenty five shares of the Company`s issued and outstanding common stock will be automatically converted into one issued and outstanding share of common stock, without any change in par value per share. The reverse stock split will affect all shares of the Company`s common stock outstanding immediately prior to the effective time of the reverse stock split, as well as the number of shares of common stock available for issuance under the Company`s equity incentive plans. In addition, the reverse stock split will effect a reduction in the number of shares of common stock issuable upon the exercise of stock options or warrants outstanding immediately prior to the effectiveness of the reverse stock split. No fractional shares will be issued as a result of the reverse stock split. The Company`s common stock will begin trading on the OTC QB on a split-adjusted basis when the market opens on Thursday, August 1, 2013. The new CUSIP number for the Company`s common stock following the reverse stock split is 83587F 202.

Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
81 Sorrento Therapeutics, Inc. [graphic]Julius Wong-October 12
80FDA accepts Sorrento's resubmitted marketing application for ZTlido, action Julius Wong-September 12
79FDA OKs Sorrento's IND for non-opioid pain candidate resiniferatoxin, clinicJulius Wong-June 30
78 Sorrento Therapeutics' Pain Subsidiary, SCILEX Pharmaceuticals, Announces PJulius Wong-June 14
77 Form 8-K stocknewsflow.comJulius Wong-June 14
76Getting ready for the bounce back up. [graphic]hollyhunter-May 23
75 Major owner of Sorrento Therapeutics, Inc. just declared owning 8,132,536 shareJulius Wong-April 27
74Sorrento Therapeutics up 9% as CEO adds to stake CEO Henry Ji took down 100K shaJulius Wong-April 19
73 Major owner of Sorrento Therapeutics, Inc. just picked up 2,500,000 shares coJulius Wong-April 17
72Appreciate the linksjonsol-April 15
71I don't have good knowledge about the company. ****** From blog.thevcf.coJulius Wong-April 15
70Any thoughts on the recent offering; clues on why, where it might head?jonsol-April 15
69Sorrento readies equity offering; shares sink 27% after hours Sorrento TherapeutJulius Wong-April 12
68SRNE Form 10-K Wong-March 22
67 Insider buying Feb 03, at $5.15 elite.finviz.comJulius Wong-February 3
66 Form 8-K for SORRENTO THERAPEUTICS, INC. In consideration for the rights granJulius Wong-7/11/2016
65 Sorrento and Servier Enter Into Exclusive Worldwide License and Collaboration AJulius Wong-7/11/2016
64 Form 8-K for SORRENTO THERAPEUTICS, INC. As reported on the Current Report onJulius Wong-7/7/2016
63 After NantHealth IPO, Patrick Soon-Shiong Prepares for Two More bloomberg.comJulius Wong-6/4/2016
62 Only Cats Fighting At Sorrento Therapeutics (SRNE)? alanhobbes.blogspot.comJulius Wong-5/10/2016
61 Wildcat Capital Issues Letter to Board of Sorrento Therapeutics Demonstrates tJulius Wong-5/6/2016
60 Form 8-K April 3, 2016 stocknewsflow.comJulius Wong-4/5/2016
59 Sorrento Announces Definitive Agreements for up to $150 Million Private PlacemeJulius Wong-4/4/2016
58 Major owner of Sorrento Therapeutics, Inc. just disposed of 100,000 shares coJulius Wong-3/14/2016
57according to prospectus, after dilution, the NPV of NK is only about $4/share. Wteevee-2/17/2016
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2017 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.